Analysi of the role of cartducin, a novel growth factor secreted from cartilage, on bone development

软骨分泌的新型生长因子cartducin对骨发育的作用分析

基本信息

  • 批准号:
    18592062
  • 负责人:
  • 金额:
    $ 2.43万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 财政年份:
    2006
  • 资助国家:
    日本
  • 起止时间:
    2006 至 2007
  • 项目状态:
    已结题

项目摘要

Several growth factors and hormones regulate bone development. However, the molecular mechanisms are not thoroughly understood. We previously identified novel secretory protein from cartilage, and named it "cartducin". Our recent studies cleared that cartducin promotes proliferation of chondroprogenitor cells and chondrocytes. In this project, we first examined whether cartducin exists in serum and further investigated the intracellular signaling pathways stimulated by cartducin in mesenchymal chondroprogenitor cells. Our first analysis showed that cartducin was undetectable in mouse serum. Next, chondroprogenitor cells were stimulated with cartducin, and three major groups of mitogen-activated protein kinase (MAPK) pathways and the phosphatidylinositol 3-kinase (PI3K)/Akt signaling pathway were examined. Cartducin activated extracellular signal-regulated kinase 1/2 (ERK1/2) and Akt, and inhibition of these pathways by specific inhibitors blocked cartducin-induced DNA synthesis in chon … More droprogenitor cells. These data suggest that cartducin is a peripheral skeletal growth factor, and the proliferation of mesenchymal chondroprogenitor cells stimulated by cartducin is associated with activations of the ERK1/2 and PI3K/Akt signaling pathways. Furthermore, we hypothesized that cartducin is an anti-angiogenic factor because cartducin was expressed in avascular zone of cartilage. Our further analysis showed that cartducin promoted proliferation and migration of mouse endothelial cells. Stimulation of these cells by cartducin led to activation of ERK1/2 and p38 MAPK. Inhibition of ERK1/2 or p38 MAPK pathways by specific inhibitors blocked the cartducin-induced endothelial cell proliferation, and migration was blocked by inhibition of ERK1/2, but not p38 MAPK pathway. These results suggest that cartducin may be involved as a novel angiogenic factor in bone development. Taken together, our study indicates that cartducin plays important roles in regulating bone development as both a growth factor and an angiogenic factor through specific signaling pathways. Less
几种生长因子和激素调节骨发育。然而,其分子机制尚未完全了解。我们以前从软骨中鉴定了一种新的分泌蛋白,并将其命名为“cartducin”。我们最近的研究表明,cartducin促进软骨祖细胞和软骨细胞的增殖。在本项目中,我们首先检测cartducin是否存在于血清中,并进一步研究cartducin在间充质软骨祖细胞中刺激的细胞内信号通路。我们的第一次分析表明,在小鼠血清中检测不到cartducin。接下来,用cartducin刺激软骨祖细胞,并检查三组主要的促分裂原活化蛋白激酶(MAPK)途径和磷脂酰肌醇3-激酶(PI 3 K)/Akt信号传导途径。Cartducin激活细胞外信号调节激酶1/2(ERK 1/2)和Akt,通过特异性抑制剂抑制这些途径可阻断Cartducin诱导的chon细胞DNA合成。 ...更多信息 前体细胞这些数据表明,cartducin是一种外周骨骼生长因子,并且由cartducin刺激的间充质软骨祖细胞的增殖与ERK 1/2和PI 3 K/Akt信号通路的激活相关。此外,我们假设cartducin是一种抗血管生成因子,因为cartducin在软骨的无血管区表达。我们的进一步分析表明,cartducin促进小鼠内皮细胞的增殖和迁移。cartducin刺激这些细胞导致ERK 1/2和p38 MAPK的激活。特异性抑制剂抑制ERK 1/2或p38 MAPK通路可阻断cartducin诱导的内皮细胞增殖,抑制ERK 1/2可阻断内皮细胞迁移,而抑制p38 MAPK通路则无作用。这些结果表明,cartducin可能参与作为一种新的血管生成因子在骨发育。总之,我们的研究表明,cartducin通过特定的信号通路作为生长因子和血管生成因子在调节骨发育中起重要作用。少

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
CTRP3/cartducin promotes proliferation and migration of endothelial cells
  • DOI:
    10.1007/s11010-007-9506-6
  • 发表时间:
    2007-10-01
  • 期刊:
  • 影响因子:
    4.3
  • 作者:
    Akiyama, Hironori;Furukawa, Souhei;Maeda, Takashi
  • 通讯作者:
    Maeda, Takashi
Cartducin stimulates mesenchymal chondroprogenitor cell proliferation through both extracellular signal-regulated kinase and phosphatidylinositol 3-kinase/Akt pathways
  • DOI:
    10.1111/j.1742-4658.2006.05240.x
  • 发表时间:
    2006-05-01
  • 期刊:
  • 影响因子:
    5.4
  • 作者:
    Akiyama, H;Furukawa, S;Maeda, T
  • 通讯作者:
    Maeda, T
ClqTNFファミリー分泌蛋白CTRP3/cartducinの血管内皮細胞に対する増殖および遊走促進作用
ClqTNF家族分泌蛋白CTRP3/cartducin对血管内皮细胞增殖和迁移的促进作用
  • DOI:
  • 发表时间:
    2007
  • 期刊:
  • 影响因子:
    0
  • 作者:
    ○前田 隆史;脇坂 聡
  • 通讯作者:
    脇坂 聡
C1qTNFファミリー分泌蛋白CTRP3/cartducinの血管内皮細胞に対する増殖および遊走促進作用
C1qTNF家族分泌蛋白CTRP3/cartducin对血管内皮细胞增殖和迁移的促进作用
  • DOI:
  • 发表时间:
    2007
  • 期刊:
  • 影响因子:
    0
  • 作者:
    ○前田 隆史;脇坂 聡
  • 通讯作者:
    脇坂 聡
C1qTNF-related protein-3 (CTRP3)/cartducin promotes proliferation and Association migration of endothelial cells
C1qTNF 相关蛋白 3 (CTRP3)/cartducin 促进内皮细胞增殖和联合迁移
  • DOI:
  • 发表时间:
    2007
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Maeda;T;Wakisaka;S
  • 通讯作者:
    S
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

MAEDA Takashi其他文献

人工知能により労働者のメンタルヘルス不調を精神科医よりも高精度で判定
人工智能比精神科医生更准确地确定工人的心理健康问题
  • DOI:
  • 发表时间:
    2022
  • 期刊:
  • 影响因子:
    0
  • 作者:
    SHIGEMURA Hiroaki;MAEDA Takashi;NAKAYAMA Shiko;OHISHI Akira;CARLE Yuki;OOKUMA Eiko;ETOH Yoshiki;HIRAI Shinichiro;MATSUI Mari;KIMURA Hirokazu;SEKIZUKA Tsuyoshi;KURODA Makoto;SERA Nobuyuki;INOSHIMA Yasuo;MURAKAMI Koichi;道喜将太郎; 笹原信一朗; 堀大介; 大井雄一; 髙橋司; 池田有; 池田朝彦; 新井陽; 室井慧; 松崎一葉
  • 通讯作者:
    道喜将太郎; 笹原信一朗; 堀大介; 大井雄一; 髙橋司; 池田有; 池田朝彦; 新井陽; 室井慧; 松崎一葉

MAEDA Takashi的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('MAEDA Takashi', 18)}}的其他基金

Identification of receptor for cartducin, and analysis of the role of cartducin in inflammation
Cartducin受体的鉴定及其在炎症中的作用分析
  • 批准号:
    18K09534
  • 财政年份:
    2018
  • 资助金额:
    $ 2.43万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
A Study of The Factors Influencing Learning Outcomes of Medical Students
医学生学习成果影响因素研究
  • 批准号:
    26780472
  • 财政年份:
    2014
  • 资助金额:
    $ 2.43万
  • 项目类别:
    Grant-in-Aid for Young Scientists (B)
Potential role of cartducin as a novel regulator of skeletal myogenic differentiation and maturation
Cartducin 作为骨骼肌原性分化和成熟的新型调节剂的潜在作用
  • 批准号:
    26462836
  • 财政年份:
    2014
  • 资助金额:
    $ 2.43万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Study on Local Tax Autonomy in the Decentralized Fiscal System
分权财政体制下的地方税收自治研究
  • 批准号:
    23530396
  • 财政年份:
    2011
  • 资助金额:
    $ 2.43万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Study of Student Culture of Part-time Course in High School from The Reconstruction Period after World War II to The period of Economic High Growth in Japan
日本二战后重建时期到经济高速增长时期高中兼读制学生文化研究
  • 批准号:
    20830108
  • 财政年份:
    2008
  • 资助金额:
    $ 2.43万
  • 项目类别:
    Grant-in-Aid for Young Scientists (Start-up)
A Study on the Desirable Real Estate Tax as Main Local Tax in the Aged Society
老龄化社会理想的房地产税作为主要地方税的研究
  • 批准号:
    20530277
  • 财政年份:
    2008
  • 资助金额:
    $ 2.43万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Analysis of the elevated expression of cartducin gene in osteosarcoma and the mechanisms of tumor development
骨肉瘤中cartducin基因表达升高及肿瘤发生机制分析
  • 批准号:
    20592197
  • 财政年份:
    2008
  • 资助金额:
    $ 2.43万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Development of a Collaborative e-Learning System and Educational Methods Based on Enquity-Based Learning and Adaptive Instruction Methodology
基于知识学习和适应性教学方法的协作电子学习系统和教育方法的开发
  • 批准号:
    17300271
  • 财政年份:
    2005
  • 资助金额:
    $ 2.43万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Am application of Kempf complex to hyper-discriminant
Kempf 复合体在超判别中的应用
  • 批准号:
    14540035
  • 财政年份:
    2002
  • 资助金额:
    $ 2.43万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
ANALYSIS OF CYTOTOXIC MECHANISMS OF ACTIVATED EOSINOPHILS IN BILIARY CELL INJURY : ESTABLISHMENT OF AN ANIMAL MODEL FOR PRIMARY BILIARY CIRRHOSIS
胆道细胞损伤中活化的嗜酸性粒细胞的细胞毒机制分析:原发性胆汁性肝硬化动物模型的建立
  • 批准号:
    09670555
  • 财政年份:
    1997
  • 资助金额:
    $ 2.43万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)

相似海外基金

Therapeutic Application of Painless Nerve Growth Factor to Accelerate Endochondral Fracture Repair
无痛神经生长因子加速软骨内骨折修复的治疗应用
  • 批准号:
    10882542
  • 财政年份:
    2021
  • 资助金额:
    $ 2.43万
  • 项目类别:
Therapeutic Application of Painless Nerve Growth Factor to Accelerate Endochondral Fracture Repair
无痛神经生长因子加速软骨内骨折修复的治疗应用
  • 批准号:
    10211755
  • 财政年份:
    2021
  • 资助金额:
    $ 2.43万
  • 项目类别:
Therapeutic Application of Painless Nerve Growth Factor to Accelerate Endochondral Fracture Repair
无痛神经生长因子加速软骨内骨折修复的治疗应用
  • 批准号:
    10662506
  • 财政年份:
    2021
  • 资助金额:
    $ 2.43万
  • 项目类别:
Growth Factor Based on Enhancement of Bone Repair
基于增强骨修复的生长因子
  • 批准号:
    9440342
  • 财政年份:
    2017
  • 资助金额:
    $ 2.43万
  • 项目类别:
The Role of PGRN Growth Factor in Osteoarthritis
PGRN 生长因子在骨关节炎中的作用
  • 批准号:
    8698896
  • 财政年份:
    2013
  • 资助金额:
    $ 2.43万
  • 项目类别:
Human Osteoprogenitor Control by Hepatocyte Growth Factor and Vitamin D
肝细胞生长因子和维生素 D 对人类骨祖细胞的控制
  • 批准号:
    8334112
  • 财政年份:
    2012
  • 资助金额:
    $ 2.43万
  • 项目类别:
p63 Regulation of Human Osteoprogenitor Maturation by Hepatocyte Growth Factor & Vitamin D Metabolites
p63 肝细胞生长因子对人类骨祖细胞成熟的调节
  • 批准号:
    9350492
  • 财政年份:
    2012
  • 资助金额:
    $ 2.43万
  • 项目类别:
Human Osteoprogenitor Control by Hepatocyte Growth Factor and Vitamin D
肝细胞生长因子和维生素 D 对人类骨祖细胞的控制
  • 批准号:
    8698316
  • 财政年份:
    2012
  • 资助金额:
    $ 2.43万
  • 项目类别:
Human Osteoprogenitor Control by Hepatocyte Growth Factor and Vitamin D
肝细胞生长因子和维生素 D 对人类骨祖细胞的控制
  • 批准号:
    8536083
  • 财政年份:
    2012
  • 资助金额:
    $ 2.43万
  • 项目类别:
p63 Regulation of Human Osteoprogenitor Maturation by Hepatocyte Growth Factor & Vitamin D Metabolites
p63 肝细胞生长因子对人类骨祖细胞成熟的调节
  • 批准号:
    9512550
  • 财政年份:
    2012
  • 资助金额:
    $ 2.43万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了